SPC

SpaceX is preparing its Starship rocket for its first orbital launch attempt. The flight would mark a major milestone for the company's next-generation, fully reusable heavy-lift rocket, which is central to NASA's Moon plans and Elon Musk's long-term ambitions for missions to Mars. Observers are watching closely for a launch date and for whether the vehicle can reach orbit on its first try.

Space-related stocks including SpaceX-linked names, AST SpaceMobile and Rocket Lab appear to have found a floor after steep losses in July. Sentiment got a boost from Elon Musk, who said NASA's vision of a permanent Moon base 'will happen'. Investors are watching whether renewed Moon ambition translates into sustained recovery for the sector.

Chosun Ilbo reports exclusively that the South Korean government is considering ending a national artificial intelligence project and is weighing a special purpose company structure as an alternative. The report has drawn attention to the fate of state-backed AI plans, with officials said to be reviewing whether the current approach should be abandoned or reorganised. Details of the project's scale and timeline were not disclosed.

Coverage claims SpaceX has gone public under the ticker SPCX and that shares jumped 19% in their debut, with analysts debating whether the stock can keep rising ahead of the company's first earnings report. Investors are weighing whether the post-IPO momentum is sustainable or driven by short-term hype. Note: SpaceX has not previously confirmed an IPO, so details remain uncertain.

The first lockup period following SpaceX's public listing has ended, and SPCX shares did not crash as some had feared. Attention is now turning to whether lingering supply overhang — early holders still waiting to sell — will weigh on the stock, with analysts divided on how much selling pressure remains in the market.

A Nature publication describes a rational framework for choosing between SpCas9 and variant-derived adenine base editors when editing the human genome. The work aims to help researchers match editor choice to specific target sites and desired edits, improving precision in gene-editing applications. The paper is being circulated among readers following advances in CRISPR-based genome editing tools.

A new analysis argues that investors are mispricing SpaceX-linked exposure, suggesting the market is failing to properly value the company and its related tickers. The piece contends that sentiment rather than fundamentals is driving trading around SpaceX and its NASDAQ-listed vehicles. Commentators are debating whether space-sector valuations reflect reality or hype.

Cloudflare has released cf, a new agentic command-line tool that replaces its long-standing Wrangler CLI and gives access to around 3,000 API operations. Developer communities are discussing what the change means for existing deployment workflows and how an AI-driven interface could reshape infrastructure management for Cloudflare's platform.

The ticker $SPCX is circulating among retail traders and finance accounts, drawing speculation about its connection to SpaceX exposure in public markets. Posters are debating whether it represents a legitimate listing or a speculative proxy for Elon Musk's space company, with little confirmed detail available.